BEIJING, April 11 /Xinhua-PRNewswire-FirstCall/ -- China Medical
Technologies, Inc. (the ''Company'') (Nasdaq: CMED), a leading China-based
medical device company that develops, manufactures and markets advanced
in-vitro diagnostic products and high intensity focused ultrasound tumor
therapy systems, today announced that it will report its unaudited
financial results for the fourth quarter and fiscal year ended March 31,
2008 (''FY2007''), declare annual cash dividend for FY2007 and provide
annual targets for the fiscal year ending March 31, 2009 (''FY2008'')
before the U.S. market opens on June 12, 2008. The Company's fiscal year
ends on March 31. The Company's management will host an earnings conference
call at 8:00 a.m., Eastern Time on the same day of the earnings
announcement (8:00 p.m. Beijing/Hong Kong time).
The dial-in details for the live conference call are as follows:
-- U.S. Toll Free Number 1-800-260-8140
-- International dial-in number 1-617-614-3672
A live webcast of the conference call will be available on http://ir.chinameditech.com .
A replay of this webcast will be available for one month on this website.
A telephone replay of the call will be available after the conclusion
of the conference call through 10:00 a.m. Eastern Time on June 13, 2008.
The dial-in details for the replay are as follows:
-- U.S. Toll Free Number 1-888-286-8010
-- International dial-in number 1-617-801-6888
About China Medical Technologies, Inc.
China Medical Technologies is a leading China-based medical device
company that develops, manufactures and markets advanced in-vitro
diagnostic products using Enhanced Chemiluminescence (ECLIA) technology and
Fluorescent in situ Hybridization (FISH) technology, to detect and monitor
various diseases and disorders, and products using High Intensity Focused
Ultrasound (HIFU) for the treatment of solid cancers and benign tumors. For
more information, please visit http://www.chinameditech.com .
For more information, please contact:
|SOURCE China Medical Technologies, Inc.|
Copyright©2008 PR Newswire.
All rights reserved